Christophe Barnier-Quer
Impact in
-
- Immunotherapy and Immune Responses
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
Papers in
-
- Immunotherapy and Immune Responses 8
- Immune Response and Inflammation 3
-
- Animal Virus Infections Studies 4
- Co-authors
- Nicolas Collin (18 shared papers)Wim Jiskoot (2 shared papers)Eleni Maria Varypataki (1 shared paper)Ana L Silva (1 shared paper)FERRY A. OSSENDORP (1 shared paper)Stefan G. Romeijn (1 shared paper)Alexander Kros (1 shared paper)Livia Brunner (5 shared papers)
- Journals
- Vaccines (5 papers)Journal of Controlled Release (2 papers)New Biotechnology (1 paper)Nanomaterials (1 paper)npj Vaccines (1 paper)
- Partner nations
- SwitzerlandNetherlandsFrance
In The Last Decade
Christophe Barnier-Quer
18 papers receiving 399 citations
Peers
Comparison fields: 5 of 55
- Immunology 191
- Pharmaceutical Science 51
- Microbiology 51
- Animal Science and Zoology 58
- Infectious Diseases 87
Countries citing papers authored by Christophe Barnier-Quer
This map shows the geographic impact of Christophe Barnier-Quer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christophe Barnier-Quer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christophe Barnier-Quer more than expected).
Fields of papers citing papers by Christophe Barnier-Quer
This network shows the impact of papers produced by Christophe Barnier-Quer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christophe Barnier-Quer. The network helps show where Christophe Barnier-Quer may publish in the future.
Co-authors
The 25 scholars most cited alongside Christophe Barnier-Quer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 92 | |
| 2 | 2013 | 53 | |
| 3 | 2019 | 43 | |
| 4 | 2019 | 37 | |
| 5 | 2016 | 21 | |
| 6 | 2017 | 18 | |
| 7 | 2019 | 18 | |
| 8 | 2018 | 17 | |
| 9 | 2020 | 16 | |
| 10 | 2019 | 15 | |
| 11 | 2020 | 13 | |
| 12 | 2016 | 13 | |
| 13 | 2015 | 12 | |
| 14 | 2019 | 11 | |
| 15 | 2018 | 11 | |
| 16 | 2021 | 9 | |
| 17 | 2021 | 5 | |
| 18 | 2017 | 2 | |
| 19 | 2018 | 0 |
About Christophe Barnier-Quer
Christophe Barnier-Quer is a scholar working on Immunology, Animal Science and Zoology, Microbiology, Epidemiology and Infectious Diseases, having authored 19 papers that have together received 406 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Animal Virus Infections Studies (4 papers), Influenza Virus Research Studies (4 papers), RNA Interference and Gene Delivery (4 papers), Viral gastroenteritis research and epidemiology (3 papers), Immune Response and Inflammation (3 papers), vaccines and immunoinformatics approaches (2 papers) and Respiratory viral infections research (2 papers). The work is most often cited by research in Immunology (191 citations), Pharmaceutical Science (51 citations), Microbiology (51 citations), Animal Science and Zoology (58 citations) and Infectious Diseases (87 citations). Christophe Barnier-Quer has collaborated with scholars based in Switzerland, Netherlands and France. Frequent co-authors include Nicolas Collin, Wim Jiskoot, Eleni Maria Varypataki, Ana L Silva, FERRY A. OSSENDORP, Stefan G. Romeijn, Alexander Kros, Livia Brunner, Gerrit Borchard and Gaël Auray. Their work appears in journals such as Vaccines, Journal of Controlled Release, New Biotechnology, Nanomaterials and npj Vaccines.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.